Sleep Disturbances and Pulmonary Artery/Aorta Diameter in Scleroderma Patient

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00566137

Acronym

Scleroderma

Enrollment

Registered

2007-12-03

Start date

2006-02-28

Completion date

2007-02-28

Last updated

2010-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Hypertension, Scleroderma

Keywords

Scleroderma, Pulmonary Hypertension

Brief summary

To determine sleep disturbance, pulmonary function test, 6 minute walk, echocardiogram abnormality, arterial blood gas, ventilation/perfusion scan of the chest in Scleroderma patient with Pulmonary Hypertension.

Detailed description

As above

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

* Patient must have Scleroderma

Exclusion criteria

* Patients who do not have Scleroderma

Outcome results